2018
DOI: 10.3892/br.2018.1146
|View full text |Cite
|
Sign up to set email alerts
|

Understanding psoriasis: Role of miRNAs (Review)

Abstract: Psoriasis is a chronic, immune-mediated inflammatory skin disease, with a multifactorial etiology and important immunologic, genetic and environmental components. Psoriasis vulgaris represents its most common form, with a variable prevalence across the globe. Although its pathogenesis remains to be fully elucidated, a lack of balance in the epigenetic network has been shown to trigger certain elements of this disease, possibly altering its outcome. MicroRNAs are small non-coding RNA molecules involved in RNA-s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
41
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(41 citation statements)
references
References 44 publications
0
41
0
Order By: Relevance
“…miRNA-21, -31, -146), but on the other hand, others revealed downregulation of miRNA (e.g. miRNA-145-5p, -197) in patients with active psoriasis [37,38,39]. A recent study by Wu et al showed new miRNA in psoriasis, which happens to be one of the most investigated…”
Section: State Of Knowledgementioning
confidence: 99%
“…miRNA-21, -31, -146), but on the other hand, others revealed downregulation of miRNA (e.g. miRNA-145-5p, -197) in patients with active psoriasis [37,38,39]. A recent study by Wu et al showed new miRNA in psoriasis, which happens to be one of the most investigated…”
Section: State Of Knowledgementioning
confidence: 99%
“…These mature transcripts regulate expression of their target genes at post-transcriptional level. Dysregulation in the expression of these transcripts contribute in the pathogenesis of psoriasis [ 22 ]. Fig.…”
Section: Mirnas and Psoriasismentioning
confidence: 99%
“…The upregulation of miR-155, together with miR-146a, is consistently associated with this 'classically' activated MP profile; however, the immunomodulatory role of miR-146a in the MP response has not been clearly defined [41][42][43][44][45][46]. Regardless, due to their typical expression profile in degenerations, miR-155 and miR-146a have been suggested as therapeutic targets in numerous inflammation-associated conditions, such as systemic lupus erythematosus [47], psoriasis [48], rheumatoid arthritis and neurodegenerative conditions including, amyotrophic lateral sclerosis (ALS), Alzheimer's disease and AMD [24,26,31,[49][50][51].…”
Section: Introductionmentioning
confidence: 99%